DPCR and QPCR Market Will Reach of USD 2165.8 Million By 2028 With A CAGR of 7.3% - Valuates Reports

BANGALORE, India, June 14, 2022 /PRNewswire/ -- The global DPCR and QPCR market is segmented by Type - dPCR, qPCR, by Application -Clinical, Research Institution, Other. Global Opportunity Analysis and Industry Forecast, 2022-2028. It is published in Valuates Reports under the Computer Science Category.

The global DPCR and QPCR market size is estimated to be worth USD 1419.2 million in 2022 and is forecast to be a readjusted size of USD 2165.8 million by 2028 with a CAGR of 7.3% during the review period.

Target diseases and genetic anomalies are becoming more common, necessitating the need for quick, precise, and accurate results. Furthermore, disease diagnosis via biomarker profiling is becoming more widespread. The qPCR market is predicted to increase as a result of these factors.

Browse The Table of Contents And List of Figures At https://reports.valuates.com/market-reports/QYRE-Auto-22I2176/global-digital-pcr-dpcr-and-real-time-pcr-qpcr

TRENDS INFLUENCING THE GROWTH OF DPCR AND QPCR MARKET

The increasing use of qPCR in Gene Expression, Pathogen Detection, Environmental Studies, siRNA, miRNA, lncRNA Detection, and Microarray Validation is expected to boost the qPCR market ahead.

Furthermore, qPCR provides quick, precise, and reliable findings. Real-time PCR is a kind of PCR that collects data while the reaction is ongoing, improving accuracy and removing the need for time-consuming post-PCR processes. As a result of this factor, the qPCR market is expected to grow. In research labs, qPCR tests are often used to determine the number of copies of a gene (gene dosage) in transformed cell lines or the existence of mutant genes. To precisely quantify changes in gene expression, qPCR testing can be used in conjunction with reverse-transcription PCR (RT-PCR).

The increased use of dPCR in cancer research and clinical microbiology is expected to boost the dPCR market. dPCR has also been widely used in a range of applications, such as mutation/SNP detection, genome editing detection, copy number variation, and standards validation.

In addition to basic research, clinical diagnostics, and environmental testing, digital PCR has a wide range of applications. Pathogen detection and digestive health analysis, liquid biopsy for cancer monitoring, organ transplant rejection monitoring, and non-invasive prenatal testing for serious genetic abnormalities, copy number variation analysis, single gene expression analysis, rare sequence detection, gene expression profiling, and single-cell analysis, as well as the detection of DNA contaminants in bioprocessing, are just a few of the applications. Furthermore, dPCR is frequently used as an orthogonal technique to confirm rare mutations found by next-generation sequencing (NGS) as well as to validate NGS libraries.

Digital droplet PCR and quantitative polymerase chain reaction (qPCR) are excellent technologies for identifying small changes in the expression of a biomarker in response to therapeutic therapy. As a result, the increasing use of biomarker profiling for disease detection is expected to propel the qPCR and dPCR markets even higher.

Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-22I2176/Global_Digital_PCR_dPCR_and_Real_Time_PCR_qPCR_Market

COVID-19 IMPACT ON THE DPCR AND QPCR MARKET

The pandemic of COVID-19 had a major influence on the healthcare business. The diagnostics industry took the worst of the blow, with the PCR market seeing a large increase. Digital PCR and real-time PCR have sparked a lot of attention since they are utilized for diagnostic and drug discovery. Industry participants are increasingly focused on developing a droplet digital PCR kit to detect COVID-19. In order to lessen the effects of the COVID-19 pandemic, regulatory bodies have voiced significant support for authorizing these tests.

TOP COMPANIES IN THE DPCR AND QPCR MARKET

In the global Digital PCR (DPCR) and QPCR markets, Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, and others are among the main players. Around 75% of the qPCR and dPCR business is controlled by the top five producers in the globe.

QPCR AND DPCR MARKET SHARE ANALYSIS:

The most common product is qPCR, which accounts for more than 70% of the market. In terms of application, the most popular is Research Use, followed by Clinical Use.

North America is the most important market, accounting for over half of total share, followed by Europe and China, each accounting for over 40%. North America's dominance is due to the existence of large PCR manufacturers in the region, as well as increased demand for rapid diagnostic tests, which is expected to fuel regional expansion.

Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-22I2176/Global_Digital_PCR_dPCR_and_Real_Time_PCR_qPCR_Market

Market By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-22I2176/Global_Digital_PCR_dPCR_and_Real_Time_PCR_qPCR_Market

Key players

• Thermo Fisher
• Roche
• QIAGEN
• Bio-rad
• Agilent
• Bioer
• Biosynex
• Esco
• Analytik Jena
• Techne
• Fluidigm
• RainDance Technologies

Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-22I2176/Global_Digital_PCR_dPCR_and_Real_Time_PCR_qPCR_Market

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-22I2176&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

-  The global digital polymerase chain reaction market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.

-  Polymerase Chain Reaction (PCR) market size is estimated to be worth USD 6632.8 million in 2022 and is forecast to be a readjusted size of USD 8868.3 million by 2028 with a CAGR of 5.0% during the review period.

-  The global qPCR and dPCR Instrumentation market was valued at USD 1158 million in 2020 and is expected to reach USD 1895.5 million by the end of 2027, growing at a CAGR of 7.3% during 2021-2027.

-  The global antimicrobial susceptibility testing market size was valued at USD 3040.00 million in 2020 and is projected to reach USD 4736.03 million by 2030 registering a CAGR of 5.8% from 2021 to 2030.

-  The global Bioreactors market size is estimated to be worth USD 1523.1 million in 2022 and is forecast to be a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.

-  The global Cell Analysis market size is projected to reach USD 25610 Million by 2027, from USD 19740 Million in 2020, at a Compound Annual Growth Rate (CAGR) of 3.7% during 2021-2027.

-  The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

-  The global Automated Cell Culture Market was valued at USD 212 million in 2020 and is expected to reach USD 358.8 million by the end of 2027, growing at a CAGR of 7.9% during 2021-2027.

-  The global digital therapeutics market size was valued at USD 2.88 Billion in 2019 and is expected to reach USD 13.80 Billion by 2027 with a CAGR of 20.5% during the forecast period.

-  The genetic testing market accounted for USD 12,682 Million in 2019, and is expected to reach USD 21,260 Million by 2027, registering a CAGR of 10.1% from 2020 to 2027.

-  The global Hemodialysis market size is estimated to be worth USD 2018.1 million in 2022 and is forecasted to reach USD 2206.7 million by 2028 with a CAGR of 1.5% during the review period.

-  The global Lab Automation market size is estimated to be worth USD 13760 Million in 2022 and is forecast to a readjusted size of USD 19820 Million by 2028 with a CAGR of 6.3% during the forecast period 2022-2028.

-  The global Medical Tubing market size is estimated to be worth USD 8136.6 million in 2022 and is forecast to be a readjusted size of USD 13570 million by 2028 with a CAGR of 8.9% during the review period.

-  The global Neurostimulation Devices market size is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.

-  The global Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.

-  The global next generation sequencing market size was valued at USD 4,533 million in 2018, and is estimated to reach USD 18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.

-  The global Medical Supplies market size is projected to reach USD 329030 Million by 2028, from USD 202430 Million in 2021, at a CAGR of 7.1% during 2022-2028.

-  The global Disposable Medical Supplies market size is projected to reach USD 293760 Million by 2027, from USD 210170 Million in 2020, at a CAGR of 4.9% during 2021-2027.

-  Global Digital PCR Platform Market Research Report

Click Here To See Related Reports on Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:

Valuates Reports 
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com  
Twitter - https://twitter.com/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg